nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR4—Peptide GPCRs—CXCR4—sarcoma	0.00927	0.0453	CbGpPWpGaD
Octreotide—SSTR3—Peptide GPCRs—CXCR4—sarcoma	0.00702	0.0344	CbGpPWpGaD
Octreotide—SSTR1—Peptide GPCRs—CXCR4—sarcoma	0.00673	0.0329	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—HBA1—sarcoma	0.00606	0.0296	CbGpPWpGaD
Octreotide—SSTR5—Peptide GPCRs—CXCR4—sarcoma	0.00597	0.0292	CbGpPWpGaD
Octreotide—SSTR2—Peptide GPCRs—CXCR4—sarcoma	0.00551	0.027	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—HBA1—sarcoma	0.00493	0.0241	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CD34—sarcoma	0.0049	0.024	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—MYOD1—sarcoma	0.0049	0.024	CbGpPWpGaD
Octreotide—SSTR4—Peptide ligand-binding receptors—CXCR4—sarcoma	0.00436	0.0213	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—HBA1—sarcoma	0.00391	0.0192	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—CXCR4—sarcoma	0.00368	0.018	CbGpPWpGaD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.00341	0.0167	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—CXCR4—sarcoma	0.0033	0.0162	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—CXCR4—sarcoma	0.00317	0.0155	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00292	0.0143	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—CXCR4—sarcoma	0.00281	0.0137	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—CXCR4—sarcoma	0.00279	0.0136	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—CXCR4—sarcoma	0.00267	0.0131	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—CXCR4—sarcoma	0.00259	0.0127	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.00259	0.0127	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—IL2—sarcoma	0.00254	0.0124	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.00248	0.0121	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—CXCR4—sarcoma	0.00237	0.0116	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CXCR4—sarcoma	0.00223	0.0109	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00222	0.0108	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.0022	0.0108	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—CXCR4—sarcoma	0.00219	0.0107	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00212	0.0104	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.00203	0.00993	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.00199	0.00972	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00188	0.00922	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—KIT—sarcoma	0.00188	0.00918	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00174	0.00851	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CXCR4—sarcoma	0.00169	0.00825	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CREB1—sarcoma	0.00163	0.00795	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CXCR4—sarcoma	0.00162	0.00791	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IL2—sarcoma	0.0016	0.00783	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCR4—sarcoma	0.00143	0.00702	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—JUN—sarcoma	0.00143	0.00699	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.00142	0.00693	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CXCR4—sarcoma	0.00132	0.00648	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CCND1—sarcoma	0.00129	0.0063	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CXCR4—sarcoma	0.00126	0.00615	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.00125	0.0061	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—JUN—sarcoma	0.00117	0.00572	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.00116	0.00568	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CXCR4—sarcoma	0.00114	0.00559	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—NRAS—sarcoma	0.00111	0.00542	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TLE1—sarcoma	0.00106	0.00518	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—MYC—sarcoma	0.00103	0.00505	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—sarcoma	0.00103	0.00503	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.00102	0.005	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—KRAS—sarcoma	0.000954	0.00467	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCR4—sarcoma	0.000953	0.00466	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCR4—sarcoma	0.000914	0.00447	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFC—sarcoma	0.000894	0.00437	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCR4—sarcoma	0.000866	0.00424	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCR4—sarcoma	0.00083	0.00406	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—HRAS—sarcoma	0.000811	0.00397	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCR4—sarcoma	0.000811	0.00397	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TLE1—sarcoma	0.000803	0.00393	CbGpPWpGaD
Octreotide—Pancreatitis—Epirubicin—sarcoma	0.000788	0.000991	CcSEcCtD
Octreotide—Abdominal pain upper—Doxorubicin—sarcoma	0.000786	0.000988	CcSEcCtD
Octreotide—Urticaria—Mitoxantrone—sarcoma	0.000779	0.000979	CcSEcCtD
Octreotide—Anorexia—Etoposide—sarcoma	0.000777	0.000977	CcSEcCtD
Octreotide—Diarrhoea—Thiotepa—sarcoma	0.000777	0.000976	CcSEcCtD
Octreotide—Abdominal pain—Mitoxantrone—sarcoma	0.000775	0.000974	CcSEcCtD
Octreotide—Body temperature increased—Mitoxantrone—sarcoma	0.000775	0.000974	CcSEcCtD
Octreotide—Bronchitis—Epirubicin—sarcoma	0.000773	0.000972	CcSEcCtD
Octreotide—Diarrhoea—Dactinomycin—sarcoma	0.000771	0.000969	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—TLE1—sarcoma	0.00077	0.00377	CbGpPWpGaD
Octreotide—Nasopharyngitis—Doxorubicin—sarcoma	0.00077	0.000967	CcSEcCtD
Octreotide—Gastritis—Doxorubicin—sarcoma	0.000762	0.000957	CcSEcCtD
Octreotide—Muscular weakness—Doxorubicin—sarcoma	0.000759	0.000954	CcSEcCtD
Octreotide—Dysuria—Epirubicin—sarcoma	0.000752	0.000945	CcSEcCtD
Octreotide—Dizziness—Thiotepa—sarcoma	0.000751	0.000944	CcSEcCtD
Octreotide—Abdominal distension—Doxorubicin—sarcoma	0.000749	0.000941	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—CXCR4—sarcoma	0.000748	0.00366	CbGpPWpGaD
Octreotide—Upper respiratory tract infection—Epirubicin—sarcoma	0.000747	0.000939	CcSEcCtD
Octreotide—Asthma—Doxorubicin—sarcoma	0.000744	0.000935	CcSEcCtD
Octreotide—Influenza—Doxorubicin—sarcoma	0.000744	0.000935	CcSEcCtD
Octreotide—Pollakiuria—Epirubicin—sarcoma	0.000743	0.000934	CcSEcCtD
Octreotide—Hypersensitivity—Vincristine—sarcoma	0.000742	0.000932	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CXCR4—sarcoma	0.000736	0.0036	CbGpPWpGaD
Octreotide—Paraesthesia—Etoposide—sarcoma	0.000732	0.000921	CcSEcCtD
Octreotide—Weight increased—Epirubicin—sarcoma	0.000732	0.00092	CcSEcCtD
Octreotide—Pancreatitis—Doxorubicin—sarcoma	0.000729	0.000917	CcSEcCtD
Octreotide—Weight decreased—Epirubicin—sarcoma	0.000727	0.000914	CcSEcCtD
Octreotide—Dyspnoea—Etoposide—sarcoma	0.000727	0.000914	CcSEcCtD
Octreotide—Hyperglycaemia—Epirubicin—sarcoma	0.000725	0.000912	CcSEcCtD
Octreotide—Somnolence—Etoposide—sarcoma	0.000725	0.000911	CcSEcCtD
Octreotide—Hypersensitivity—Mitoxantrone—sarcoma	0.000722	0.000908	CcSEcCtD
Octreotide—Asthenia—Vincristine—sarcoma	0.000722	0.000908	CcSEcCtD
Octreotide—Vomiting—Thiotepa—sarcoma	0.000722	0.000907	CcSEcCtD
Octreotide—Pneumonia—Epirubicin—sarcoma	0.000721	0.000906	CcSEcCtD
Octreotide—Drowsiness—Epirubicin—sarcoma	0.000717	0.000901	CcSEcCtD
Octreotide—Vomiting—Dactinomycin—sarcoma	0.000717	0.000901	CcSEcCtD
Octreotide—Rash—Thiotepa—sarcoma	0.000716	0.0009	CcSEcCtD
Octreotide—Bronchitis—Doxorubicin—sarcoma	0.000715	0.000899	CcSEcCtD
Octreotide—Dermatitis—Thiotepa—sarcoma	0.000715	0.000899	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—FLT1—sarcoma	0.000715	0.0035	CbGpPWpGaD
Octreotide—Headache—Thiotepa—sarcoma	0.000711	0.000894	CcSEcCtD
Octreotide—Rash—Dactinomycin—sarcoma	0.000711	0.000893	CcSEcCtD
Octreotide—Decreased appetite—Etoposide—sarcoma	0.000709	0.000891	CcSEcCtD
Octreotide—Gastrointestinal disorder—Etoposide—sarcoma	0.000704	0.000885	CcSEcCtD
Octreotide—Asthenia—Mitoxantrone—sarcoma	0.000704	0.000884	CcSEcCtD
Octreotide—Fatigue—Etoposide—sarcoma	0.000703	0.000884	CcSEcCtD
Octreotide—Neuropathy peripheral—Epirubicin—sarcoma	0.000703	0.000883	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—PLCG1—sarcoma	0.000702	0.00344	CbGpPWpGaD
Octreotide—Jaundice—Epirubicin—sarcoma	0.000699	0.000878	CcSEcCtD
Octreotide—Pain—Etoposide—sarcoma	0.000697	0.000877	CcSEcCtD
Octreotide—Constipation—Etoposide—sarcoma	0.000697	0.000877	CcSEcCtD
Octreotide—Conjunctivitis—Epirubicin—sarcoma	0.000697	0.000876	CcSEcCtD
Octreotide—Urinary tract infection—Epirubicin—sarcoma	0.000697	0.000876	CcSEcCtD
Octreotide—Dysuria—Doxorubicin—sarcoma	0.000696	0.000874	CcSEcCtD
Octreotide—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000691	0.000869	CcSEcCtD
Octreotide—Diarrhoea—Vincristine—sarcoma	0.000689	0.000866	CcSEcCtD
Octreotide—Pollakiuria—Doxorubicin—sarcoma	0.000687	0.000864	CcSEcCtD
Octreotide—Haematuria—Epirubicin—sarcoma	0.000683	0.000859	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—TLE1—sarcoma	0.000683	0.00334	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCR4—sarcoma	0.000679	0.00332	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Epirubicin—sarcoma	0.000678	0.000852	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—VEGFC—sarcoma	0.000677	0.00331	CbGpPWpGaD
Octreotide—Weight increased—Doxorubicin—sarcoma	0.000677	0.000851	CcSEcCtD
Octreotide—Epistaxis—Epirubicin—sarcoma	0.000676	0.00085	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CXCR4—sarcoma	0.000675	0.0033	CbGpPWpGaD
Octreotide—Nausea—Thiotepa—sarcoma	0.000674	0.000848	CcSEcCtD
Octreotide—Weight decreased—Doxorubicin—sarcoma	0.000673	0.000846	CcSEcCtD
Octreotide—Sinusitis—Epirubicin—sarcoma	0.000673	0.000845	CcSEcCtD
Octreotide—Feeling abnormal—Etoposide—sarcoma	0.000672	0.000845	CcSEcCtD
Octreotide—Hyperglycaemia—Doxorubicin—sarcoma	0.000671	0.000843	CcSEcCtD
Octreotide—Diarrhoea—Mitoxantrone—sarcoma	0.000671	0.000843	CcSEcCtD
Octreotide—Nausea—Dactinomycin—sarcoma	0.000669	0.000841	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—ATF1—sarcoma	0.000667	0.00326	CbGpPWpGaD
Octreotide—Pneumonia—Doxorubicin—sarcoma	0.000667	0.000839	CcSEcCtD
Octreotide—Gastrointestinal pain—Etoposide—sarcoma	0.000667	0.000838	CcSEcCtD
Octreotide—Dizziness—Vincristine—sarcoma	0.000666	0.000837	CcSEcCtD
Octreotide—Drowsiness—Doxorubicin—sarcoma	0.000663	0.000834	CcSEcCtD
Octreotide—Bradycardia—Epirubicin—sarcoma	0.000655	0.000823	CcSEcCtD
Octreotide—Neuropathy peripheral—Doxorubicin—sarcoma	0.00065	0.000817	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—VEGFC—sarcoma	0.000649	0.00318	CbGpPWpGaD
Octreotide—Urticaria—Etoposide—sarcoma	0.000648	0.000814	CcSEcCtD
Octreotide—Jaundice—Doxorubicin—sarcoma	0.000647	0.000813	CcSEcCtD
Octreotide—Rhinitis—Epirubicin—sarcoma	0.000645	0.000811	CcSEcCtD
Octreotide—Body temperature increased—Etoposide—sarcoma	0.000645	0.00081	CcSEcCtD
Octreotide—Abdominal pain—Etoposide—sarcoma	0.000645	0.00081	CcSEcCtD
Octreotide—Urinary tract infection—Doxorubicin—sarcoma	0.000645	0.00081	CcSEcCtD
Octreotide—Conjunctivitis—Doxorubicin—sarcoma	0.000645	0.00081	CcSEcCtD
Octreotide—Hepatitis—Epirubicin—sarcoma	0.000644	0.000809	CcSEcCtD
Octreotide—Hypoaesthesia—Epirubicin—sarcoma	0.00064	0.000805	CcSEcCtD
Octreotide—Vomiting—Vincristine—sarcoma	0.00064	0.000805	CcSEcCtD
Octreotide—Pharyngitis—Epirubicin—sarcoma	0.000639	0.000803	CcSEcCtD
Octreotide—Rash—Vincristine—sarcoma	0.000635	0.000798	CcSEcCtD
Octreotide—Dermatitis—Vincristine—sarcoma	0.000634	0.000797	CcSEcCtD
Octreotide—Oedema peripheral—Epirubicin—sarcoma	0.000634	0.000797	CcSEcCtD
Octreotide—Haematuria—Doxorubicin—sarcoma	0.000632	0.000795	CcSEcCtD
Octreotide—Headache—Vincristine—sarcoma	0.000631	0.000793	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—TLE1—sarcoma	0.00063	0.00308	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Doxorubicin—sarcoma	0.000627	0.000788	CcSEcCtD
Octreotide—Epistaxis—Doxorubicin—sarcoma	0.000626	0.000786	CcSEcCtD
Octreotide—Vomiting—Mitoxantrone—sarcoma	0.000623	0.000784	CcSEcCtD
Octreotide—Sinusitis—Doxorubicin—sarcoma	0.000622	0.000782	CcSEcCtD
Octreotide—Visual impairment—Epirubicin—sarcoma	0.00062	0.000779	CcSEcCtD
Octreotide—Rash—Mitoxantrone—sarcoma	0.000618	0.000777	CcSEcCtD
Octreotide—Dermatitis—Mitoxantrone—sarcoma	0.000618	0.000776	CcSEcCtD
Octreotide—Headache—Mitoxantrone—sarcoma	0.000614	0.000772	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—CREB1—sarcoma	0.000612	0.00299	CbGpPWpGaD
Octreotide—Bradycardia—Doxorubicin—sarcoma	0.000606	0.000762	CcSEcCtD
Octreotide—Hypersensitivity—Etoposide—sarcoma	0.000601	0.000755	CcSEcCtD
Octreotide—Tinnitus—Epirubicin—sarcoma	0.0006	0.000754	CcSEcCtD
Octreotide—Nausea—Vincristine—sarcoma	0.000598	0.000752	CcSEcCtD
Octreotide—Cardiac disorder—Epirubicin—sarcoma	0.000597	0.000751	CcSEcCtD
Octreotide—Flushing—Epirubicin—sarcoma	0.000597	0.000751	CcSEcCtD
Octreotide—Rhinitis—Doxorubicin—sarcoma	0.000597	0.00075	CcSEcCtD
Octreotide—Hepatitis—Doxorubicin—sarcoma	0.000595	0.000748	CcSEcCtD
Octreotide—Hypoaesthesia—Doxorubicin—sarcoma	0.000592	0.000745	CcSEcCtD
Octreotide—Pharyngitis—Doxorubicin—sarcoma	0.000591	0.000743	CcSEcCtD
Octreotide—Oedema peripheral—Doxorubicin—sarcoma	0.000587	0.000737	CcSEcCtD
Octreotide—Asthenia—Etoposide—sarcoma	0.000585	0.000736	CcSEcCtD
Octreotide—Nausea—Mitoxantrone—sarcoma	0.000582	0.000732	CcSEcCtD
Octreotide—Immune system disorder—Epirubicin—sarcoma	0.000581	0.000731	CcSEcCtD
Octreotide—Pruritus—Etoposide—sarcoma	0.000577	0.000725	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—VEGFC—sarcoma	0.000576	0.00282	CbGpPWpGaD
Octreotide—Arrhythmia—Epirubicin—sarcoma	0.000575	0.000723	CcSEcCtD
Octreotide—Visual impairment—Doxorubicin—sarcoma	0.000574	0.000721	CcSEcCtD
Octreotide—Alopecia—Epirubicin—sarcoma	0.000569	0.000715	CcSEcCtD
Octreotide—Mental disorder—Epirubicin—sarcoma	0.000564	0.000709	CcSEcCtD
Octreotide—Malnutrition—Epirubicin—sarcoma	0.00056	0.000704	CcSEcCtD
Octreotide—Erythema—Epirubicin—sarcoma	0.00056	0.000704	CcSEcCtD
Octreotide—Diarrhoea—Etoposide—sarcoma	0.000558	0.000701	CcSEcCtD
Octreotide—Tinnitus—Doxorubicin—sarcoma	0.000555	0.000698	CcSEcCtD
Octreotide—Flushing—Doxorubicin—sarcoma	0.000553	0.000695	CcSEcCtD
Octreotide—Cardiac disorder—Doxorubicin—sarcoma	0.000553	0.000695	CcSEcCtD
Octreotide—Flatulence—Epirubicin—sarcoma	0.000552	0.000694	CcSEcCtD
Octreotide—Tension—Epirubicin—sarcoma	0.00055	0.000691	CcSEcCtD
Octreotide—Nervousness—Epirubicin—sarcoma	0.000544	0.000684	CcSEcCtD
Octreotide—Back pain—Epirubicin—sarcoma	0.000542	0.000681	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—FLT1—sarcoma	0.000542	0.00265	CbGpPWpGaD
Octreotide—Dizziness—Etoposide—sarcoma	0.000539	0.000678	CcSEcCtD
Octreotide—Muscle spasms—Epirubicin—sarcoma	0.000539	0.000677	CcSEcCtD
Octreotide—Immune system disorder—Doxorubicin—sarcoma	0.000538	0.000676	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PLCG1—sarcoma	0.000532	0.0026	CbGpPWpGaD
Octreotide—Arrhythmia—Doxorubicin—sarcoma	0.000532	0.000669	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—VEGFC—sarcoma	0.000532	0.0026	CbGpPWpGaD
Octreotide—Vision blurred—Epirubicin—sarcoma	0.000528	0.000664	CcSEcCtD
Octreotide—Alopecia—Doxorubicin—sarcoma	0.000526	0.000661	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—IGF1R—sarcoma	0.000524	0.00256	CbGpPWpGaD
Octreotide—Mental disorder—Doxorubicin—sarcoma	0.000522	0.000656	CcSEcCtD
Octreotide—Ill-defined disorder—Epirubicin—sarcoma	0.00052	0.000653	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—FLT1—sarcoma	0.000519	0.00254	CbGpPWpGaD
Octreotide—Vomiting—Etoposide—sarcoma	0.000519	0.000652	CcSEcCtD
Octreotide—Erythema—Doxorubicin—sarcoma	0.000518	0.000651	CcSEcCtD
Octreotide—Malnutrition—Doxorubicin—sarcoma	0.000518	0.000651	CcSEcCtD
Octreotide—Anaemia—Epirubicin—sarcoma	0.000518	0.000651	CcSEcCtD
Octreotide—Agitation—Epirubicin—sarcoma	0.000515	0.000647	CcSEcCtD
Octreotide—Rash—Etoposide—sarcoma	0.000514	0.000646	CcSEcCtD
Octreotide—Dermatitis—Etoposide—sarcoma	0.000514	0.000646	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CXCR4—sarcoma	0.000511	0.0025	CbGpPWpGaD
Octreotide—Headache—Etoposide—sarcoma	0.000511	0.000642	CcSEcCtD
Octreotide—Flatulence—Doxorubicin—sarcoma	0.000511	0.000642	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PLCG1—sarcoma	0.00051	0.0025	CbGpPWpGaD
Octreotide—Tension—Doxorubicin—sarcoma	0.000509	0.000639	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—ATF1—sarcoma	0.000506	0.00247	CbGpPWpGaD
Octreotide—Malaise—Epirubicin—sarcoma	0.000505	0.000635	CcSEcCtD
Octreotide—Nervousness—Doxorubicin—sarcoma	0.000503	0.000633	CcSEcCtD
Octreotide—Vertigo—Epirubicin—sarcoma	0.000503	0.000633	CcSEcCtD
Octreotide—Syncope—Epirubicin—sarcoma	0.000502	0.000631	CcSEcCtD
Octreotide—Back pain—Doxorubicin—sarcoma	0.000501	0.00063	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—FOXO1—sarcoma	0.000498	0.00244	CbGpPWpGaD
Octreotide—Muscle spasms—Doxorubicin—sarcoma	0.000498	0.000626	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—IL2—sarcoma	0.000498	0.00244	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PDGFRB—sarcoma	0.000498	0.00243	CbGpPWpGaD
Octreotide—Palpitations—Epirubicin—sarcoma	0.000495	0.000622	CcSEcCtD
Octreotide—Loss of consciousness—Epirubicin—sarcoma	0.000492	0.000619	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CXCR4—sarcoma	0.00049	0.0024	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PDGFRA—sarcoma	0.00049	0.0024	CbGpPWpGaD
Octreotide—Cough—Epirubicin—sarcoma	0.000489	0.000614	CcSEcCtD
Octreotide—Vision blurred—Doxorubicin—sarcoma	0.000488	0.000614	CcSEcCtD
Octreotide—Convulsion—Epirubicin—sarcoma	0.000485	0.00061	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—ATF1—sarcoma	0.000485	0.00237	CbGpPWpGaD
Octreotide—Nausea—Etoposide—sarcoma	0.000484	0.000609	CcSEcCtD
Octreotide—Hypertension—Epirubicin—sarcoma	0.000484	0.000608	CcSEcCtD
Octreotide—Ill-defined disorder—Doxorubicin—sarcoma	0.000481	0.000604	CcSEcCtD
Octreotide—Anaemia—Doxorubicin—sarcoma	0.000479	0.000602	CcSEcCtD
Octreotide—Chest pain—Epirubicin—sarcoma	0.000477	0.000599	CcSEcCtD
Octreotide—Arthralgia—Epirubicin—sarcoma	0.000477	0.000599	CcSEcCtD
Octreotide—Myalgia—Epirubicin—sarcoma	0.000477	0.000599	CcSEcCtD
Octreotide—Agitation—Doxorubicin—sarcoma	0.000476	0.000599	CcSEcCtD
Octreotide—Anxiety—Epirubicin—sarcoma	0.000475	0.000597	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000474	0.000595	CcSEcCtD
Octreotide—Discomfort—Epirubicin—sarcoma	0.000471	0.000592	CcSEcCtD
Octreotide—Malaise—Doxorubicin—sarcoma	0.000467	0.000588	CcSEcCtD
Octreotide—Dry mouth—Epirubicin—sarcoma	0.000466	0.000586	CcSEcCtD
Octreotide—Vertigo—Doxorubicin—sarcoma	0.000466	0.000585	CcSEcCtD
Octreotide—Syncope—Doxorubicin—sarcoma	0.000465	0.000584	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—CREB1—sarcoma	0.000464	0.00227	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FLT1—sarcoma	0.00046	0.00225	CbGpPWpGaD
Octreotide—Palpitations—Doxorubicin—sarcoma	0.000458	0.000576	CcSEcCtD
Octreotide—Oedema—Epirubicin—sarcoma	0.000457	0.000575	CcSEcCtD
Octreotide—Anaphylactic shock—Epirubicin—sarcoma	0.000457	0.000575	CcSEcCtD
Octreotide—Loss of consciousness—Doxorubicin—sarcoma	0.000456	0.000573	CcSEcCtD
Octreotide—Infection—Epirubicin—sarcoma	0.000454	0.000571	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PLCG1—sarcoma	0.000453	0.00221	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL2—sarcoma	0.000452	0.00221	CbGpPWpGaD
Octreotide—Cough—Doxorubicin—sarcoma	0.000452	0.000569	CcSEcCtD
Octreotide—Shock—Epirubicin—sarcoma	0.00045	0.000565	CcSEcCtD
Octreotide—Convulsion—Doxorubicin—sarcoma	0.000449	0.000564	CcSEcCtD
Octreotide—Nervous system disorder—Epirubicin—sarcoma	0.000448	0.000564	CcSEcCtD
Octreotide—Thrombocytopenia—Epirubicin—sarcoma	0.000448	0.000563	CcSEcCtD
Octreotide—Hypertension—Doxorubicin—sarcoma	0.000448	0.000562	CcSEcCtD
Octreotide—Tachycardia—Epirubicin—sarcoma	0.000446	0.000561	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—CREB1—sarcoma	0.000445	0.00218	CbGpPWpGaD
Octreotide—Skin disorder—Epirubicin—sarcoma	0.000444	0.000558	CcSEcCtD
Octreotide—Hyperhidrosis—Epirubicin—sarcoma	0.000442	0.000556	CcSEcCtD
Octreotide—Myalgia—Doxorubicin—sarcoma	0.000441	0.000555	CcSEcCtD
Octreotide—Chest pain—Doxorubicin—sarcoma	0.000441	0.000555	CcSEcCtD
Octreotide—Arthralgia—Doxorubicin—sarcoma	0.000441	0.000555	CcSEcCtD
Octreotide—Anxiety—Doxorubicin—sarcoma	0.00044	0.000553	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000438	0.000551	CcSEcCtD
Octreotide—Discomfort—Doxorubicin—sarcoma	0.000436	0.000548	CcSEcCtD
Octreotide—Anorexia—Epirubicin—sarcoma	0.000436	0.000548	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CXCR4—sarcoma	0.000435	0.00213	CbGpPWpGaD
Octreotide—Dry mouth—Doxorubicin—sarcoma	0.000432	0.000542	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—ATF1—sarcoma	0.00043	0.0021	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FLT1—sarcoma	0.000425	0.00208	CbGpPWpGaD
Octreotide—Oedema—Doxorubicin—sarcoma	0.000423	0.000532	CcSEcCtD
Octreotide—Anaphylactic shock—Doxorubicin—sarcoma	0.000423	0.000532	CcSEcCtD
Octreotide—Infection—Doxorubicin—sarcoma	0.00042	0.000528	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PLCG1—sarcoma	0.000418	0.00204	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000417	0.000524	CcSEcCtD
Octreotide—Shock—Doxorubicin—sarcoma	0.000416	0.000523	CcSEcCtD
Octreotide—Nervous system disorder—Doxorubicin—sarcoma	0.000415	0.000521	CcSEcCtD
Octreotide—Thrombocytopenia—Doxorubicin—sarcoma	0.000414	0.000521	CcSEcCtD
Octreotide—Insomnia—Epirubicin—sarcoma	0.000414	0.00052	CcSEcCtD
Octreotide—Tachycardia—Doxorubicin—sarcoma	0.000413	0.000519	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—KDR—sarcoma	0.000412	0.00202	CbGpPWpGaD
Octreotide—Skin disorder—Doxorubicin—sarcoma	0.000411	0.000516	CcSEcCtD
Octreotide—Paraesthesia—Epirubicin—sarcoma	0.000411	0.000516	CcSEcCtD
Octreotide—Hyperhidrosis—Doxorubicin—sarcoma	0.000409	0.000514	CcSEcCtD
Octreotide—Dyspnoea—Epirubicin—sarcoma	0.000408	0.000512	CcSEcCtD
Octreotide—Somnolence—Epirubicin—sarcoma	0.000406	0.000511	CcSEcCtD
Octreotide—Anorexia—Doxorubicin—sarcoma	0.000403	0.000507	CcSEcCtD
Octreotide—Dyspepsia—Epirubicin—sarcoma	0.000402	0.000506	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CXCR4—sarcoma	0.000401	0.00196	CbGpPWpGaD
Octreotide—Decreased appetite—Epirubicin—sarcoma	0.000397	0.0005	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—ATF1—sarcoma	0.000397	0.00194	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1R—sarcoma	0.000397	0.00194	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000395	0.000496	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CREB1—sarcoma	0.000394	0.00193	CbGpPWpGaD
Octreotide—Fatigue—Epirubicin—sarcoma	0.000394	0.000495	CcSEcCtD
Octreotide—Constipation—Epirubicin—sarcoma	0.000391	0.000491	CcSEcCtD
Octreotide—Pain—Epirubicin—sarcoma	0.000391	0.000491	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000385	0.000484	CcSEcCtD
Octreotide—Insomnia—Doxorubicin—sarcoma	0.000383	0.000481	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—IGF1R—sarcoma	0.00038	0.00186	CbGpPWpGaD
Octreotide—Paraesthesia—Doxorubicin—sarcoma	0.00038	0.000477	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—KIT—sarcoma	0.00038	0.00186	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—NRAS—sarcoma	0.00038	0.00186	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FOXO1—sarcoma	0.000378	0.00185	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—IL2—sarcoma	0.000378	0.00185	CbGpPWpGaD
Octreotide—Dyspnoea—Doxorubicin—sarcoma	0.000377	0.000474	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PDGFRB—sarcoma	0.000377	0.00184	CbGpPWpGaD
Octreotide—Feeling abnormal—Epirubicin—sarcoma	0.000377	0.000474	CcSEcCtD
Octreotide—Somnolence—Doxorubicin—sarcoma	0.000376	0.000473	CcSEcCtD
Octreotide—Gastrointestinal pain—Epirubicin—sarcoma	0.000374	0.00047	CcSEcCtD
Octreotide—Dyspepsia—Doxorubicin—sarcoma	0.000372	0.000468	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PDGFRA—sarcoma	0.000371	0.00182	CbGpPWpGaD
Octreotide—Decreased appetite—Doxorubicin—sarcoma	0.000368	0.000462	CcSEcCtD
Octreotide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000365	0.000459	CcSEcCtD
Octreotide—Fatigue—Doxorubicin—sarcoma	0.000365	0.000458	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CREB1—sarcoma	0.000364	0.00178	CbGpPWpGaD
Octreotide—Urticaria—Epirubicin—sarcoma	0.000363	0.000457	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—FOXO1—sarcoma	0.000362	0.00177	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2—sarcoma	0.000362	0.00177	CbGpPWpGaD
Octreotide—Constipation—Doxorubicin—sarcoma	0.000362	0.000455	CcSEcCtD
Octreotide—Pain—Doxorubicin—sarcoma	0.000362	0.000455	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CREB1—sarcoma	0.000361	0.00177	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PDGFRB—sarcoma	0.000361	0.00177	CbGpPWpGaD
Octreotide—Abdominal pain—Epirubicin—sarcoma	0.000361	0.000454	CcSEcCtD
Octreotide—Body temperature increased—Epirubicin—sarcoma	0.000361	0.000454	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PDGFRA—sarcoma	0.000356	0.00174	CbGpPWpGaD
Octreotide—Feeling abnormal—Doxorubicin—sarcoma	0.000349	0.000438	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—EGFR—sarcoma	0.000346	0.00169	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000346	0.000435	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—IL2—sarcoma	0.000343	0.00168	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1R—sarcoma	0.000337	0.00165	CbGpPWpGaD
Octreotide—Hypersensitivity—Epirubicin—sarcoma	0.000337	0.000423	CcSEcCtD
Octreotide—Urticaria—Doxorubicin—sarcoma	0.000336	0.000422	CcSEcCtD
Octreotide—Abdominal pain—Doxorubicin—sarcoma	0.000334	0.00042	CcSEcCtD
Octreotide—Body temperature increased—Doxorubicin—sarcoma	0.000334	0.00042	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—IL2—sarcoma	0.000329	0.00161	CbGpPWpGaD
Octreotide—Asthenia—Epirubicin—sarcoma	0.000328	0.000412	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—KRAS—sarcoma	0.000327	0.0016	CbGpPWpGaD
Octreotide—Pruritus—Epirubicin—sarcoma	0.000323	0.000407	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—FOXO1—sarcoma	0.000321	0.00157	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2—sarcoma	0.000321	0.00157	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PDGFRB—sarcoma	0.000321	0.00157	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PDGFRA—sarcoma	0.000316	0.00154	CbGpPWpGaD
Octreotide—Diarrhoea—Epirubicin—sarcoma	0.000313	0.000393	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—KDR—sarcoma	0.000312	0.00153	CbGpPWpGaD
Octreotide—Hypersensitivity—Doxorubicin—sarcoma	0.000312	0.000392	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—IGF1R—sarcoma	0.000311	0.00152	CbGpPWpGaD
Octreotide—Asthenia—Doxorubicin—sarcoma	0.000304	0.000381	CcSEcCtD
Octreotide—Dizziness—Epirubicin—sarcoma	0.000302	0.00038	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—KDR—sarcoma	0.0003	0.00147	CbGpPWpGaD
Octreotide—Pruritus—Doxorubicin—sarcoma	0.000299	0.000376	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—MDM2—sarcoma	0.000299	0.00146	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FOXO1—sarcoma	0.000296	0.00145	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—sarcoma	0.000296	0.00145	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PDGFRB—sarcoma	0.000296	0.00145	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2—sarcoma	0.000292	0.00143	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PDGFRA—sarcoma	0.000291	0.00143	CbGpPWpGaD
Octreotide—Vomiting—Epirubicin—sarcoma	0.000291	0.000365	CcSEcCtD
Octreotide—Diarrhoea—Doxorubicin—sarcoma	0.000289	0.000364	CcSEcCtD
Octreotide—Rash—Epirubicin—sarcoma	0.000288	0.000362	CcSEcCtD
Octreotide—Dermatitis—Epirubicin—sarcoma	0.000288	0.000362	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—KIT—sarcoma	0.000288	0.00141	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—NRAS—sarcoma	0.000288	0.00141	CbGpPWpGaD
Octreotide—Headache—Epirubicin—sarcoma	0.000286	0.00036	CcSEcCtD
Octreotide—Dizziness—Doxorubicin—sarcoma	0.00028	0.000352	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—HRAS—sarcoma	0.000278	0.00136	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KIT—sarcoma	0.000276	0.00135	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—NRAS—sarcoma	0.000276	0.00135	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CREB1—sarcoma	0.000274	0.00134	CbGpPWpGaD
Octreotide—Nausea—Epirubicin—sarcoma	0.000272	0.000341	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—IL2—sarcoma	0.000269	0.00132	CbGpPWpGaD
Octreotide—Vomiting—Doxorubicin—sarcoma	0.000269	0.000338	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—IL2—sarcoma	0.000267	0.00131	CbGpPWpGaD
Octreotide—Rash—Doxorubicin—sarcoma	0.000267	0.000335	CcSEcCtD
Octreotide—Dermatitis—Doxorubicin—sarcoma	0.000266	0.000335	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—KDR—sarcoma	0.000266	0.0013	CbGpPWpGaD
Octreotide—Headache—Doxorubicin—sarcoma	0.000265	0.000333	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CREB1—sarcoma	0.000263	0.00129	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—sarcoma	0.000262	0.00128	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCND1—sarcoma	0.000261	0.00127	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—JUN—sarcoma	0.00026	0.00127	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CTNNB1—sarcoma	0.000258	0.00126	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—sarcoma	0.000251	0.00123	CbGpPWpGaD
Octreotide—Nausea—Doxorubicin—sarcoma	0.000251	0.000316	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—KRAS—sarcoma	0.000248	0.00121	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—sarcoma	0.000245	0.0012	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KIT—sarcoma	0.000245	0.0012	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—NRAS—sarcoma	0.000245	0.0012	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—sarcoma	0.000237	0.00116	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SRC—sarcoma	0.000233	0.00114	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CREB1—sarcoma	0.000233	0.00114	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—sarcoma	0.000227	0.00111	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MDM2—sarcoma	0.000227	0.00111	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KIT—sarcoma	0.000226	0.0011	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—NRAS—sarcoma	0.000226	0.0011	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NRAS—sarcoma	0.000224	0.0011	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—sarcoma	0.000223	0.00109	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MDM2—sarcoma	0.000217	0.00106	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CREB1—sarcoma	0.000215	0.00105	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—sarcoma	0.000211	0.00103	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—sarcoma	0.000211	0.00103	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—sarcoma	0.000209	0.00102	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—sarcoma	0.000206	0.00101	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—sarcoma	0.000204	0.001	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—sarcoma	0.000203	0.000991	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—sarcoma	0.000202	0.000988	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—sarcoma	0.000197	0.000966	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JUN—sarcoma	0.000197	0.000964	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CTNNB1—sarcoma	0.000196	0.000957	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—sarcoma	0.000194	0.000951	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—sarcoma	0.000194	0.00095	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—sarcoma	0.000193	0.000945	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MDM2—sarcoma	0.000193	0.000943	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—sarcoma	0.000189	0.000926	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JUN—sarcoma	0.000189	0.000924	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CTNNB1—sarcoma	0.000187	0.000917	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—sarcoma	0.000179	0.000876	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MDM2—sarcoma	0.000178	0.00087	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SRC—sarcoma	0.000177	0.000865	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—sarcoma	0.000172	0.000843	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—sarcoma	0.000172	0.000842	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—sarcoma	0.000172	0.00084	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NRAS—sarcoma	0.00017	0.000832	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SRC—sarcoma	0.000169	0.000829	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—sarcoma	0.000168	0.000821	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—JUN—sarcoma	0.000168	0.00082	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CTNNB1—sarcoma	0.000166	0.000813	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—sarcoma	0.000165	0.000808	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—sarcoma	0.000165	0.000807	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—sarcoma	0.000164	0.000803	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NRAS—sarcoma	0.000163	0.000797	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—sarcoma	0.000159	0.000778	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—sarcoma	0.000158	0.000775	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—sarcoma	0.000155	0.000758	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—sarcoma	0.000155	0.000758	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JUN—sarcoma	0.000155	0.000756	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CTNNB1—sarcoma	0.000153	0.000751	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—sarcoma	0.000152	0.000743	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SRC—sarcoma	0.00015	0.000735	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—sarcoma	0.000149	0.000727	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—sarcoma	0.000146	0.000716	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—sarcoma	0.000146	0.000716	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NRAS—sarcoma	0.000145	0.000707	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—sarcoma	0.00014	0.000686	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SRC—sarcoma	0.000139	0.000678	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—sarcoma	0.000135	0.000661	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—sarcoma	0.000135	0.000659	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NRAS—sarcoma	0.000133	0.000653	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—sarcoma	0.000132	0.000644	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—sarcoma	0.00013	0.000636	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—sarcoma	0.000125	0.00061	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—sarcoma	0.000124	0.000609	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—sarcoma	0.000124	0.000609	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—sarcoma	0.000124	0.000608	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—sarcoma	0.000122	0.000595	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—sarcoma	0.000119	0.000583	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—sarcoma	0.000115	0.000562	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—sarcoma	0.000111	0.000541	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—sarcoma	0.000106	0.000517	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—sarcoma	0.000102	0.000499	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—sarcoma	9.76e-05	0.000478	CbGpPWpGaD
